CS Clinic ApS
APSDissolvedAdvertising protectionCVR 43678973Nyvej 16C, 1851 Frederiksberg CTraditional, complementary and alternative medicine activities· NACE 8696Est. 2022 · 3 years old1 employees
Loading company…
Overview
CS Clinic ApS is a Danish APS based in Frederiksberg C, operating in the Traditional, complementary and alternative medicine activities sector. Incorporated in 2022, the company has 1 employee and reported a gross profit of DKK 352.1k in its latest annual filing.
Gross profit 2023
352.1K DKK
EBITDA margin (of gross profit)
−32.4 %
Net profit 2023
-113.9K DKK
1 employees
Key ratios
See full ratios →Solidity ratioEquity ÷ Total assets × 100
-846.3 %
Very weakAmong the 10% lowest rated companies in the industry
20232023
Liquidity ratioCurrent assets ÷ Short-term debt
0.1×
Very weakAmong the 10% lowest rated companies in the industry
20232023
Return on assets (ROA)Net profit ÷ Total assets × 100
<−999 %
Very weakAmong the 10% lowest rated companies in the industry
20232023
EBITDA — year on year
DKK thousandsKey figures
Annual report 2023| Gross profit | 352.1K DKK | — |
| EBITDA | -113.9K DKK | — |
| Net profit | -113.9K DKK | — |
| Total assets | 8.7K DKK | — |
| Equity | -73.9K DKK | — |
| Employees | 1 | — |
Company information
Legal name
CS Clinic ApS
CVR number
43678973
Legal form
Anpartsselskab
NACE code
Founded
21 November 2022 · 3 years
Share capital
DKK 40,000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren.
Contact
Address
Nyvej 16C, 1851 Frederiksberg C
Advertising protection
Active — opted out of marketing use
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Financial development
In its most recent annual report (2023), CS Clinic ApS reported a gross profit of DKK 352.1k. The bottom line showed a net loss of DKK 113.9k, and the EBITDA margin stood at -32.4%.
At the end of 2023, current assets covered short-term debt 0.1 times.
Financials
Gross profit
DKK thousandsEBITDA
DKK thousandsIncome statement
DKK thousands| Item | 2023 |
|---|---|
| Gross profit | 352 |
| Staff expenses | -466 |
| EBITDA | -114 |
| Depreciation & amort. | -0 |
| EBIT | -114 |
| Net financials | -0 |
| Profit before tax | -114 |
| Tax | -0 |
| Net profit | -114 |
Get a credit rating – not just the numbers
Financial statements show the past. Risika gives you a score and a recommended credit limit, so you know what the numbers mean for your risk.
Balance sheet
DKK thousands| Item | 2023 |
|---|---|
| Total assets | 9 |
| Equity | -74 |
| Long-term debt | 0 |
| Short-term debt | 83 |
| Total debt | 83 |
Financial ratios
5-year trendEBITDA margin (of gross profit)
-32.4 %
20232023
Equity ratio
-846.3 %
Very weakAmong the 10% lowest rated companies in the industry
20232023
Return on equity
—
20232023
Net profit margin (of gross profit)
-32.4 %
20232023
Asset turnover (of gross profit)
40.31×
20232023
Debt / equity
—
20232023
Sector performance
13 of 28 ratios graded28 financial ratios from the latest filing, each graded against companies in the same industry.
Profitability
Return on assets (ROA)Very weak
Among the 10% lowest rated companies in the industry
Net profit as a percentage of total assets — the return generated on the capital employed.
Basic earning power (BEP)Very weak
Among the 10% lowest rated companies in the industry
EBIT relative to total assets — the company's earning power before the effects of tax and financial leverage.
Capacity ratioWeak
Among the 30% lowest rated companies in the industry
Shows how strongly fixed costs weigh on the gross result — a high ratio means fixed costs take only a small bite out of the earnings from basic operations.
Gross marginNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
The gross result as a share of revenue — how much of the revenue is left after variable costs to cover the company's fixed costs.
Operating marginNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
EBIT as a share of revenue — the share of revenue remaining as earnings once all operating costs are covered. A key measure of earning power.
Net profit marginNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
The profit for the year as a share of revenue — the company's ability to turn revenue into profit.
Return on equity (ROE)Not rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Net profit as a percentage of equity — the return the owners earned on their invested capital this year.
Return on net assets (RONA)Not rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Profit relative to net assets (total assets minus total debt) — the ability to generate earnings from the net asset base alone.
Liquidity
Current ratioVery weak
Among the 10% lowest rated companies in the industry
Current assets relative to short-term debt — the ability to settle short-term obligations with current assets alone. Around 150% is considered satisfactory from a credit perspective.
Quick ratioVery weak
Among the 10% lowest rated companies in the industry
Current assets excluding inventory relative to short-term debt — whether the most liquid assets alone can cover the short-term obligations. A value of 1 or above signals a healthy liquidity position.
Cash ratioWeak
Among the 30% lowest rated companies in the industry
Cash relative to short-term debt — the ability to repay short-term obligations with cash alone.
Cash conversion ratioWeak
Among the 40% lowest rated companies in the industry
Cash flow relative to profit — the ability to convert reported profits into accessible cash.
Current assets to equityNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Current assets relative to equity — an indicator of the balance-sheet structure and of the company's short- and long-term financing. The healthy level is highly industry-dependent.
Fixed assets to long-term capitalNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Fixed assets relative to long-term capital (equity plus long-term liabilities). Below 100% means the long-term capital finances more than just the fixed assets — a healthier liquidity position.
Debt & solvency
Solidity ratioVery weak
Among the 10% lowest rated companies in the industry
Equity as a share of total assets — the ability to absorb losses. Around 40% is considered satisfactory from a credit perspective.
Debt ratioVery weak
Among the 10% lowest rated companies in the industry
Total debt relative to the balance-sheet total — the share of the assets financed by debt rather than equity.
Income to debtVery weak
Among the 10% lowest rated companies in the industry
Profit relative to debt — the ability to create earnings while operating with debt.
EBITDA to debtVery weak
Among the 10% lowest rated companies in the industry
EBITDA relative to debt — how much operating earnings are available to service the debt.
Interest coverageVery weak
Among the 10% lowest rated companies in the industry
The ability to pay the interest on the company's debt out of its earnings.
Debt to equityNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Debt relative to equity — the company's leverage. A higher value means heavier reliance on debt financing.
Liabilities to equityNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Total liabilities relative to equity — whether the company operates primarily on borrowed capital or on its own.
Interest rate on debtNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Financial expenses relative to total liabilities — the effective interest rate the company pays on its debt.
Interest marginNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
The return on assets minus the interest rate on debt. Positive means the company benefits from operating with debt; negative means the debt makes it worse off.
Efficiency & development
Equity to contributed capitalVery weak
Among the 10% lowest rated companies in the industry
Total equity relative to the capital the owners contributed — how the equity has developed from its starting point.
Asset turnoverNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Revenue relative to total assets — the ability to generate revenue from the asset base.
Inventory turnoverNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Revenue relative to inventory — how many times a year the inventory is sold and replaced. A low value can indicate weak sales or excess inventory.
One-year change in equityNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
The size of this year's increase or decrease in the company's equity.
One-year change in debtNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
The size of this year's increase or decrease in the company's debt.
Annual reports & filings
People & ownership
Management
Actively employed in the business| Name | Role | Member since |
|---|
Former (2)
FN Management | Management | 2023 – 2025 |
JB Management | Management | 2022 – 2023 |
Board of directors
Non-executive oversightNo data on file.
Shareholders
Active legal owners| Shareholder | Type | Ownership | Votes | Registered |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
One in three Danish companies experiences fraud
Sound familiar? See how to strengthen your defences and catch suspicious changes in ownership and management in time.
Related companies
Company hierarchy
CellSonic Holding ApS
CS Clinic ApS Board network connections
Board members of CS Clinic ApS also hold positions in 10 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Flemming Nielsen | Management | 8 companiesMany roles |
| Jette Breitenstein | Management | 2 companies |
Frequently asked questions
What is the CVR number of CS Clinic ApS?
CS Clinic ApS is registered with CVR / Virk under CVR 43678973.
What is the gross profit of CS Clinic ApS?
CS Clinic ApS reported a gross profit of DKK 352.1k in 2023.
How many employees does CS Clinic ApS have?
CS Clinic ApS employs 1 people as of the latest annual report.
Where is CS Clinic ApS headquartered?
CS Clinic ApS's registered address is Nyvej 16C.